2.2.10. VISCOSITY - ROTATING VISCOMETER METHOD
EUROPEAN PHARMACOPOEIA 7.0 2.2.10. Viscosity - Rotating viscometer method Figure 2.2.10.-2 CONE-PLATE VISCOMETERS (ABSOLUTE VISCOMETERS) In the cone-plate viscometer, the liquid is introduced into the gap between a flat disc and a cone forming a define angle. Viscosity measurement can be performed by rotating the cone
Download 2.2.10. VISCOSITY - ROTATING VISCOMETER METHOD
Information
Domain:
Source:
Link to this page:
Documents from same domain
<1117> MICROBIOLOGICAL BEST LABORATORY …
www.drugfuture.com708 〈1117〉 Microbiological Best Laboratory Practices / General Information USP 35 glassware or from prior materials used in the glassware. Be Media should be labeled properly with batch or lot num-
<1227> VALIDATION OF MICROBIAL RECOVERY …
www.drugfuture.comUSP 35 General Information / 〈1227〉 Validation of Microbial Recovery 883 〈1227〉 VALIDATION OF culture preparation. The conditions of organism preparation and storage must be standardized for the neutralizer evalua-MICROBIAL RECOVERY FROM tion and should reflect the conditions of the antimicrobial
2.2.32. LOSS ON DRYING - 药物在线-快捷药物信息 …
www.drugfuture.com2.2.33. Nuclear magnetic resonance spectrometry EUROPEAN PHARMACOPOEIA 7.0 01/2009:20233 2.2.33. NUCLEAR MAGNETIC RESONANCE SPECTROMETRY INTRODUCTION Nuclearmagneticresonance(NMR)spectrometryisananalytical
2.2.46. CHROMATOGRAPHIC SEPARATION …
www.drugfuture.com2.2.45. Supercritical fluid chromatography EUROPEAN PHARMACOPOEIA 7.0 Control solutions.In addition to the TOC water control, prepare suitable blank solutions or other solutions needed for establishing the baseline or for calibration adjustments
2.6.12. MICROBIOLOGICAL - DrugFuture
www.drugfuture.com2.6.12. Microbial enumeration tests EUROPEAN PHARMACOPOEIA 7.0 Table 2.6.12.-1. – Preparation and use of test micro-organisms Growth …
2.4. LIMIT TESTS - DrugFuture
www.drugfuture.comEUROPEAN PHARMACOPOEIA 7.0 2.4.4. Chlorides 2.4. LIMIT TESTS 01/2008:20401 2.4.1. AMMONIUM Unlessotherwiseprescribed,usemethodA. METHOD A ...
2.2. PHYSICAL AND PHYSICOCHEMICAL METHODS
www.drugfuture.com2.2.2. Degree of coloration of liquids EUROPEAN PHARMACOPOEIA 7.0 dilute suspensions containing small particles. Linearity between turbidity and concentration must be established by constructing
EUROPEAN PHARMACOPOEIA 7 - DrugFuture
www.drugfuture.com2.2.25. Absorption spectrophotometry, ultraviolet and visible EUROPEAN PHARMACOPOEIA 7.0 acquired using suitable purged instruments or ensuring that sample and background single beam spectra are acquired under
5.1.3. EFFICACY OF ANTIMICROBIAL PRESERVATION
www.drugfuture.comEUROPEAN PHARMACOPOEIA 7.0 5.1.3. Efficacy of antimicrobial preservation suspensions may be presented in sealed ampoules. Biological indicators are prepared in such a way that they can be stored
<1151> PHARMACEUTICAL DOSAGE FORMS - …
www.drugfuture.com766 〈1151〉 Pharmaceutical Dosage Forms / General Information USP 35 Figure 1. Compendial Taxonomy for Pharmaceutical Dosage Forms. volumes recommended in the accompanying table are usu- Identification—Identification tests are discussed in the
Related documents
EUROPEAN PHARMACOPOEIA 5 - uspbpep.com
uspbpep.comEUROPEAN PHARMACOPOEIA 5.0 2.9.2. Disintegration of suppositories and pessaries to a mechanical device capable of raising and lowering it smoothly at constant frequency between 29 and 32 cycles per minute, through a distance of 55 ± 2 mm. The assembly is suspended in the specified liquid medium in a suitable vessel, preferably a 1 litre beaker.
Order Reference Standard Batch Quantity Sale Code n° per ...
crs.edqm.euList of European Pharmacopoeia Reference Standards Effective from 2022/1/20 For extra charges, please see terms and conditions. List of European Pharmacopoeia Reference Standards Effective from 2022/1/20
Pharmaceutical Analysis Using UV-Vis: Compliance with USP ...
www.agilent.comThe United States pharmacopeia (USP) and the European pharmacopeia (Ph. Eur.) guidelines describe how to verify that the analytical performance of UV-Vis spectrophotometers is suitable for the intended operational range of the analysis. Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia
European Pharmacopoeia 10 Edition - EDQM
www.edqm.euEuropean Pharmacopoeia 10th Edition Single subscriptions Year Reference Item ISBN Language Price in € Handling charges in € 2020 PUB200332 Book (10.0 -10.1 10.2) 978-92-871-8921-9 English 540 60 PUB200335 Book (10.0 -10.1 10.2) 978-92-871-8922-6 French 540 60 2021 PUB200333 Book (10.3 -10.4 10.5) 978-92-871-8639-3 English 540 60
General Concepts in the European Pharmacopoeia
www.ema.europa.euEuropean Pharmacopoeia … has been prepared by a method liable to leave impurities not controlled in the pharmacopoeia monograph, these impurities and their maximum tolerance limits must be declared and a suitable test procedure must be described.”
European Medicines Agency
www.ema.europa.euFor the European Union, the monographs of the Ph. Eur. have mandatory applicability. Regulatory authorities can accept the reference in a marketing authorisation application, renewal or variation application citing the use of the corresponding text from another pharmacopoeia as referenced in Section 2.1, in accordance with the
5.1.4. MICROBIOLOGICAL QUALITY OF NON-STERILE ...
www.medicinalgenomics.comEUROPEAN PHARMACOPOEIA 7.0 5.1.4. Microbiological quality of non-sterile products for pharmaceutical use 01/2011:50104 5.1.4. MICROBIOLOGICAL QUALITY OF NON-STERILE PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL USE(1) The presence of certain micro-organisms in non-sterile preparations may have the potential to …
3.4 TEST FOR BACTERIAL ENDOTOXINS Final text for …
www.who.intThe text, reproduced with the permission of the Japanese Pharmacopoeia with appropriate editorial modifications, is one that has undergone pharmacopoeial harmonization by the Pharmacopoeial Discussion Group (PDG) of the European Pharmacopoeia (Ph.Eur), Japanese Pharmacopoeia (JP) and United States Pharmacopeia (USP).
INDEX OF PHARMACOPOEIAS - WHO
www.who.intCzech Republic 1. Czech Pharmacopoeia Commission Ministry of Health State Institute for Drug Control Šrobárova 48, 100-41 Prague 10, Czech Republic The Czech Pharmacopoeia Pharmacopoea Bohemica MMV 2. Vydala Grada Publishing a.s. Volumes 1-3 2005 Czech U Pruhonu 466/22, Praha 7-Holešovice,